Dermira (NASDAQ: DERM) reported Q2 EPS of ($0.46), $0.15 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on Dermira (DERM) click here.